ConductScience.org, home

Paper9609969

Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats.

el Daly ES. J Pharm Belg, 1998. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. Papers, record 9609969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9609969

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats.
PubMed
Journal
J Pharm Belg
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
4.49
iCite
Revised in PubMed
2022-03-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1el Daly ESE S

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CisplatinMajor topic
CysteineMajor topic
Plant ExtractsMajor topic
Plants, MedicinalMajor topic
Vitamin EMajor topic
Animals
Male
Rats

Source PubMed

Download CSV of topics

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
42671218Protective Effects of Luteolin Against Cisplatin-Induced Hepatic and Renal Toxicity: Biochemical and Cellular Evidence.J Biochem Mol Toxicol2026https://conductscience.org/library/papers/42671218PubMed
38419885An overview of pharmacological effects of Crocus sativous and its constituents.Iran J Basic Med Sci2024https://conductscience.org/library/papers/38419885PubMed
38005726Potential Pharmacological Applications of Nigella Seeds with a Focus on Nigella sativa and Its Constituents against Chronic Inflammatory Diseases: Progress and Future Opportunities.Plants (Basel)2023https://conductscience.org/library/papers/38005726PubMed
37727876
Al-Hijamah (Prophetic Wet Cupping Therapy) is a Novel Adjuvant Treatment for Viral Hepatitis That Excretes Viral Particles and Excess Ferritin Percutaneously, Synergizes Pharmacotherapy, Enhances Antiviral Immunity and Helps Better HCC Prevention and Treatment: A Novel Evidence-Based Combination with Prophetic Medicine Remedies.
J Hepatocell Carcinoma2023https://conductscience.org/library/papers/37727876PubMed
37389090Effects of saffron and its active constituent crocin on cancer management: A narrative review.Longhua Chin Med2022https://conductscience.org/library/papers/37389090PubMed
36431872Natural Reno-Protective Agents against Cyclosporine A-Induced Nephrotoxicity: An Overview.Molecules2022https://conductscience.org/library/papers/36431872PubMed
36008971Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD+-Dependent Enzymes and Plant-Derived Natural Products.Biomolecules2022https://conductscience.org/library/papers/36008971PubMed
35656071Saffron nephroprotective effects against medications and toxins: A review of preclinical data.Iran J Basic Med Sci2022https://conductscience.org/library/papers/35656071PubMed
35198096The Pharmacological Activities of Crocus sativus L.: A Review Based on the Mechanisms and Therapeutic Opportunities of its Phytoconstituents.Oxid Med Cell Longev2022https://conductscience.org/library/papers/35198096PubMed
34584648Evaluation of apoptotic effect of crocin, cisplatin, and their combination in human oral squamous cell carcinoma cell line HN5.Dent Res J (Isfahan)2021https://conductscience.org/library/papers/34584648PubMed
34445781Protective Effects of Black Cumin (Nigella sativa) and Its Bioactive Constituent, Thymoquinone against Kidney Injury: An Aspect on Pharmacological Insights.Int J Mol Sci2021https://conductscience.org/library/papers/34445781PubMed
33136014The Protective Effect of Nigella sativa Oil against Experimentally Induced Cisplatin Ototoxicity: An Animal Study.J Int Adv Otol2020https://conductscience.org/library/papers/33136014PubMed
32983848An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties.J Herb Med2021https://conductscience.org/library/papers/32983848PubMed
32711409Toxicity of Saffron Extracts on Cancer and Normal Cells: A Review Article.Asian Pac J Cancer Prev2020https://conductscience.org/library/papers/32711409PubMed
32313889Investigation of the Protective Effect of Nigella Sativa Oil in Cisplatin Induced Oral Mucositis: An Experimental Study.Turk Arch Otorhinolaryngol2020https://conductscience.org/library/papers/32313889PubMed
30832267Multiple Targets of 3-Dehydroxyceanothetric Acid 2-Methyl Ester to Protect Against Cisplatin-Induced Cytotoxicity in Kidney Epithelial LLC-PK1 Cells.Molecules2019https://conductscience.org/library/papers/30832267PubMed
29391685Prophylactic and immune modulatory influences of Nigella sativa Linn. in broilers exposed to biological challenge.Vet World2017https://conductscience.org/library/papers/29391685PubMed
28814830Comparative analysis of essential oil composition of Iranian and Indian Nigella sativa L. extracted using supercritical fluid extraction and solvent extraction.Drug Des Devel Ther2017https://conductscience.org/library/papers/28814830PubMed
28629150Role of Nigella sativa and Its Constituent Thymoquinone on Chemotherapy-Induced Nephrotoxicity: Evidences from Experimental Animal Studies.Nutrients2017https://conductscience.org/library/papers/28629150PubMed
28344496The impact of formulation attributes and process parameters on black seed oil loaded liposomes and their performance in animal models of analgesia.Saudi Pharm J2017https://conductscience.org/library/papers/28344496PubMed

See all 45 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9609969

GET https://conductscience.org/api/papers/v1/9609969/cited_by?page=2